China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
21.09
-0.11 (-0.52%)
Nov 17, 2026, 3:04 PM CST

SHE:000028 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
5,9647,8027,4096,5026,0165,126
Cash & Short-Term Investments
5,9647,8027,4096,5026,0165,126
Cash Growth
5.64%5.32%13.94%8.08%17.37%-18.44%
Accounts Receivable
24,93922,93921,11820,23516,20217,701
Other Receivables
450.69132.22146.41265.5666.8587.26
Receivables
25,39023,07121,29420,53916,30617,855
Inventory
8,4638,1227,4067,9897,8367,622
Other Current Assets
506.561,2001,4671,3401,5501,246
Total Current Assets
40,32440,19637,57636,37031,70831,848
Property, Plant & Equipment
2,3932,6923,4793,7243,4073,494
Long-Term Investments
3,3913,2783,0802,9472,7992,658
Goodwill
1,6051,6051,8592,7472,7502,776
Other Intangible Assets
373.94406.69479.54615.59647.52669.93
Long-Term Accounts Receivable
-1.7212.9315.9113.6816.59
Long-Term Deferred Tax Assets
330.52308.72249.41220.48185.25129.74
Long-Term Deferred Charges
266.07335.23467.67526.58572.55633.98
Other Long-Term Assets
219.76273.09352.1404.42532.4557.38
Total Assets
48,90449,09647,55647,57142,61642,784

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
21,65720,51618,10017,95215,23316,718
Accrued Expenses
312.7666.7779.14760.58998.17753.2
Short-Term Debt
1,4152,8553,4222,9032,1332,490
Current Portion of Long-Term Debt
---1745.14-
Current Portion of Leases
669.47740.45944.371,002867.85848.33
Current Income Taxes Payable
350.94171.63128.03205.9237.8178.87
Current Unearned Revenue
333.2387.21349.74456.3586.96450.59
Other Current Liabilities
702.68768.631,0791,041926.05939.8
Total Current Liabilities
25,44126,10524,80224,33821,02822,379
Long-Term Debt
----17.571.64
Long-Term Leases
788.78912.181,3711,4521,3271,375
Long-Term Unearned Revenue
65.7669.2869.4874.9780.9187.72
Pension & Post-Retirement Benefits
0.580.610.710.770.861.2
Long-Term Deferred Tax Liabilities
84.8793.87114.5146.05156.48175.95
Other Long-Term Liabilities
263.1290.7441.99581.45560.3670.52
Total Liabilities
26,64427,47226,80026,59323,17124,761

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
612.22556.57556.57556.57428.13428.13
Additional Paid-In Capital
4,2684,2684,2614,2614,3574,372
Retained Earnings
14,34013,78612,85412,59011,33310,103
Comprehensive Income & Other
-0.28-0.28-1.457.877.9121.87
Total Common Equity
19,22018,61017,67017,41516,12614,925
Minority Interest
3,0403,0153,0863,5633,3193,097
Shareholders' Equity
22,26021,62420,75520,97819,44518,022
Total Liabilities & Equity
48,90449,09647,55647,57142,61642,784

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,8734,5075,7375,3744,3914,786
Net Cash (Debt)
3,0923,2951,6711,1291,626340.48
Net Cash Growth
1100.43%97.18%48.07%-30.58%377.51%-82.99%
Net Cash Per Share
5.075.382.721.842.660.56
Filing Date Shares Outstanding
612.22612.22612.22612.22612.22612.22
Total Common Shares Outstanding
612.22612.22612.22612.22612.22612.22
Working Capital
14,88314,09112,77412,03210,6819,469
Book Value Per Share
31.3930.4028.8628.4526.3424.38
Tangible Book Value
17,24116,59815,33114,05312,72811,479
Tangible Book Value Per Share
28.1627.1125.0422.9520.7918.75
Buildings
-806.56807.91741.11738.01725.86
Machinery
-1,4141,3961,2941,1321,027
Construction In Progress
-21.6612.635.4435.1749.85